Tesamorelin Peptide: FDA Approved Benefits, Results Timeline, and Who It's For Perfect B CJC 1295 + Ipamorelin: Benefits, Differences, and When to Combine Revolution Health & Wellness FDA Peptide Reclassification 2026: What It Means for Providers Is Sermorelin FDA Approved? Sermorelin Therapy HealthGAINS The peptide regulatory landscape in 2026 is in active flux. After the FDA placed 19 popular peptides in Category 2 in late 2023, HHS Secretary RFK Jr. announced in February 2026 that New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,